23andMe Moves Into Serious Genomic Research

A new study using genes from the DNA-testing service made new discoveries about Parkinson’s. Now the company is poised to continue groundbreaking genetic research, at a pace much faster than traditional research. Google-backed genotyping service 23andMe is a novelty for many people: spit in a tube, send it to the company, pay $99 and find out what diseases you’re genetically prone to and whether you have any long-lost relatives who also use the service.

View original post here:
23andMe Moves Into Serious Genomic Research